Meeder Asset Management Inc Exact Sciences Corp Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Meeder Asset Management Inc holds 64 shares of EXAS stock, worth $3,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 80 20.0%

Holding current value

$3,591

Previous $3,000 33.33%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$42.43 - $70.83 $678 - $1,133	-16 Reduced 20.0%	64 $4,000
Q2 2024 Aug 08, 2024	BUY	$41.33 - $74.26 $3,306 - $5,940	80 New	80 $3,000
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $264,621 - $463,414	-8,719 Reduced 95.53%	408 $20,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $289,680 - $447,341	9,061 Added 13728.79%	9,127 $296,000
Q2 2022 Aug 08, 2022	SELL	$35.61 - $76.23 $1,424 - $3,049	-40 Reduced 37.74%	66 $3,000
Q1 2022 May 10, 2022	BUY	$57.56 - $82.54 $6,101 - $8,749	106 New	106 $7,000
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $432,680 - $600,858	-5,968 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$90.24 - $124.05 $50,714 - $69,716	562 Added 10.4%	5,968 $570,000
Q2 2021 Aug 09, 2021	BUY	$93.66 - $139.27 $93,753 - $139,409	1,001 Added 22.72%	5,406 $672,000
Q1 2021 Apr 28, 2021	BUY	$116.57 - $155.01 $505,680 - $672,433	4,338 Added 6474.63%	4,405 $580,000
Q4 2020 Feb 09, 2021	SELL	$99.61 - $142.12 $498,249 - $710,884	-5,002 Reduced 98.68%	67 $9,000
Q3 2020 Nov 02, 2020	SELL	$72.92 - $102.01 $81,889 - $114,557	-1,123 Reduced 18.14%	5,069 $516,000
Q2 2020 Aug 11, 2020	BUY	$55.75 - $92.75 $299,154 - $497,696	5,366 Added 649.64%	6,192 $538,000
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $280,573 - $773,169	-7,403 Reduced 89.96%	826 $48,000
Q4 2019 Feb 13, 2020	SELL	$77.66 - $99.74 $277,867 - $356,869	-3,578 Reduced 30.3%	8,229 $760,000
Q3 2019 Oct 17, 2019	BUY	$90.37 - $122.49 $44,462 - $60,265	492 Added 4.35%	11,807 $1.07 Million
Q2 2019 Aug 05, 2019	BUY	$89.51 - $118.04 $333,066 - $439,226	3,721 Added 49.0%	11,315 $1.34 Million
Q1 2019 Apr 16, 2019	BUY	$61.98 - $96.5 $290,314 - $452,006	4,684 Added 160.96%	7,594 $657,000
Q4 2018 Jan 17, 2019	BUY	$56.04 - $82.66 $139,875 - $206,319	2,496 Added 602.9%	2,910 $184,000
Q3 2018 Nov 02, 2018	BUY	$48.29 - $80.6 $2,221 - $3,707	46 Added 12.5%	414 $0
Q2 2018 Jul 24, 2018	SELL	$37.84 - $69.96 $2,232 - $4,127	-59 Reduced 13.82%	368 $0
Q1 2018 May 03, 2018	SELL	$39.82 - $57.53 $100,067 - $144,572	-2,513 Reduced 85.48%	427 $17,000
Q4 2017 Feb 02, 2018	BUY	$46.49 - $60.51 $35,843 - $46,653	771 Added 35.55%	2,940 $155,000
Q3 2017 Oct 20, 2017	BUY	$37.05 - $47.12 $80,361 - $102,203	2,169	2,169 $102,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.93B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Exact Sciences Corp Transaction History